Literature DB >> 25868726

Malat1 regulates serum response factor through miR-133 as a competing endogenous RNA in myogenesis.

Xiaorui Han1, Feng Yang2, Huiqing Cao2, Zicai Liang2.   

Abstract

Metastasis-associated lung adenocarcinoma transcript 1 (Malat1) is an example of a functional long noncoding RNA involved in many biologic processes. However, the mechanisms for Malat1 in myogenesis are unclear. Serum response factor (SRF) is a pivotal transcription factor for muscle proliferation and differentiation and is reported to be a target gene for muscle-specific microRNA-133 (miR-133). In this study, we initially found that silencing Malat1 in the mouse myoblast C2C12 cell line inhibited myocyte differentiation and decreased Srf at both the RNA and protein levels. Srf silencing decreased Malat1 expression as well. Further study revealed that Malat1 contained an miR-133 functional target site, and the interplay between Malat1 and Srf was miR-133 dependent. We demonstrated that Malat1 modulates Srf through miR-133 as a competing endogenous RNA and established a novel connection among Malat1, miR-133, and Srf in myoblast differentiation. © FASEB.

Entities:  

Keywords:  long noncoding RNA; microRNA; sponge

Mesh:

Substances:

Year:  2015        PMID: 25868726     DOI: 10.1096/fj.14-259952

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  59 in total

1.  A novel long non-coding RNA, lncKBTBD10, involved in bovine skeletal muscle myogenesis.

Authors:  Mingming Chen; Xin Li; Xiaojuan Zhang; Yan Li; Junxing Zhang; Minhui Liu; Linlin Zhang; Xiangbin Ding; Xinfeng Liu; Hong Guo
Journal:  In Vitro Cell Dev Biol Anim       Date:  2018-11-21       Impact factor: 2.416

2.  Long Noncoding RNA Malat1 Regulates Cerebrovascular Pathologies in Ischemic Stroke.

Authors:  Xuejing Zhang; Xuelian Tang; Kai Liu; Milton H Hamblin; Ke-Jie Yin
Journal:  J Neurosci       Date:  2017-01-16       Impact factor: 6.167

Review 3.  Long non-coding RNAs and nuclear factor-κB crosstalk in cancer and other human diseases.

Authors:  Subash C Gupta; Nikee Awasthee; Vipin Rai; Srinivas Chava; Venugopal Gunda; Kishore B Challagundla
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-10-19       Impact factor: 10.680

Review 4.  The long noncoding RNA Malat1: Its physiological and pathophysiological functions.

Authors:  Xuejing Zhang; Milton H Hamblin; Ke-Jie Yin
Journal:  RNA Biol       Date:  2017-10-06       Impact factor: 4.652

5.  MALAT1 functions as a competing endogenous RNA to mediate Rac1 expression by sequestering miR-101b in liver fibrosis.

Authors:  Fujun Yu; Zhongqiu Lu; Jing Cai; Kate Huang; Bicheng Chen; Guojun Li; Peihong Dong; Jianjian Zheng
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 6.  Long non-coding RNAs and cell death following ischemic stroke.

Authors:  Masoumeh Alishahi; Farhoodeh Ghaedrahmati; Tannaz Akbari Kolagar; William Winlow; Negin Nikkar; Maryam Farzaneh; Seyed Esmaeil Khoshnam
Journal:  Metab Brain Dis       Date:  2019-05-04       Impact factor: 3.584

7.  Long noncoding RNA SYISL regulates myogenesis by interacting with polycomb repressive complex 2.

Authors:  Jian Jun Jin; Wei Lv; Pan Xia; Zai Yan Xu; An Dai Zheng; Xiao Jing Wang; Shan Shan Wang; Rui Zeng; Hong Mei Luo; Guo Liang Li; Bo Zuo
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-02       Impact factor: 11.205

8.  Long non-coding RNA HNF1A-AS1 promotes cell viability and migration in human bladder cancer.

Authors:  Zhihong Feng; Baolong Wang
Journal:  Oncol Lett       Date:  2018-01-26       Impact factor: 2.967

Review 9.  Roles of the canonical myomiRs miR-1, -133 and -206 in cell development and disease.

Authors:  Keith Richard Mitchelson; Wen-Yan Qin
Journal:  World J Biol Chem       Date:  2015-08-26

10.  Long non-coding RNA taurine upregulated 1 enhances tumor-induced angiogenesis through inhibiting microRNA-299 in human glioblastoma.

Authors:  H Cai; X Liu; J Zheng; Y Xue; J Ma; Z Li; Z Xi; Z Li; M Bao; Y Liu
Journal:  Oncogene       Date:  2016-06-27       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.